Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger W Chapman

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Clinical Liver Disease|December 15, 2022
Primary sclerosing cholangitis-A long night's journey into dayRoger W Chapman
Clinical Liver Disease|April 18, 2019
Update on primary sclerosing cholangitisRoger W Chapman
British Journal of Hospital Medicine (London, England : 2005)|August 3, 2018
Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitisRoger W Chapman
Hepatology (Baltimore, Md.)|August 29, 2009
High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?Roger W Chapman
Nature Reviews. Gastroenterology & Hepatology|February 6, 2010
Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?Roger W Chapman
Current Gastroenterology Reports|January 18, 2003
The management of primary sclerosing cholangitisRoger W Chapman
Clinical Liver Disease|April 18, 2019
Malignancy in primary sclerosing cholangitis: Bile duct, liver, and colonRoger W Chapman
Journal of Hepatology|May 2, 2002
Small duct primary sclerosing cholangitisRoger W Chapman
Current Gastroenterology Reports|November 30, 2011
Primary sclerosing cholangitis: is any treatment worthwhile?Ashley Barnabas, Roger W Chapman
Current Opinion in Gastroenterology|February 11, 2005
Sclerosing cholangitisEinar Björnsson, Roger W Chapman
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Clinical Liver Disease|December 15, 2022
Primary sclerosing cholangitis-A long night's journey into dayRoger W Chapman
Clinical Liver Disease|April 18, 2019
Update on primary sclerosing cholangitisRoger W Chapman
British Journal of Hospital Medicine (London, England : 2005)|August 3, 2018
Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitisRoger W Chapman
Hepatology (Baltimore, Md.)|August 29, 2009
High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?Roger W Chapman
Nature Reviews. Gastroenterology & Hepatology|February 6, 2010
Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?Roger W Chapman
Current Gastroenterology Reports|January 18, 2003
The management of primary sclerosing cholangitisRoger W Chapman
Clinical Liver Disease|April 18, 2019
Malignancy in primary sclerosing cholangitis: Bile duct, liver, and colonRoger W Chapman
Journal of Hepatology|May 2, 2002
Small duct primary sclerosing cholangitisRoger W Chapman
Current Gastroenterology Reports|November 30, 2011
Primary sclerosing cholangitis: is any treatment worthwhile?Ashley Barnabas, Roger W Chapman
Current Opinion in Gastroenterology|February 11, 2005
Sclerosing cholangitisEinar Björnsson, Roger W Chapman
Pageof 7